ICICI Securities Maintains Hold on Persistent Systems, Sets Rs 5,670 Target
The research report cited 7.8% QoQ and 20.8% YoY constant-currency revenue growth, driven by a large Hitech deal ramp-up and healthy BFSI growth. Healthcare and Lifesciences were flat for a second consecutive quarter; Europe declined 10% QoQ in USD terms.